Merck Joins The Weight-Loss Race, Inking $2.01 Billion Deal To Take On Eli Lilly, Pfizer, Roche

Blockhead12-18 22:07

Merck (MRK) threw its hat into the obesity race on Wednesday, inking a deal worth up to $2.01 billion with China's Hansoh Pharma for its experimental weight-loss drug. ↑ X The Weight-Loss Drug ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492118997?lang=en_US&edition=fundamental","thumbnail":"https://www.investors.com/wp-content/uploads/2018/04/stock-Merck-03-shutter-150x150.jpg","is_english":true,"pubTime":"2024-12-18 22:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492118997","market":"us","top_or_hot":-1,"title":"Merck Joins The Weight-Loss Race, Inking $2.01 Billion Deal To Take On Eli Lilly, Pfizer, Roche","media":"Blockhead","content":"<div>\n<p>Merck (MRK) threw its hat into the obesity race on Wednesday, inking a deal worth up to $2.01 billion with China's Hansoh Pharma for its experimental weight-loss drug.\n\n\n\n↑\nX\n\n\n\n\nThe Weight-Loss Drug ...</p>\n\n<a href=\"https://www.investors.com/news/technology/merck-weight-loss-drugs-hansoh-pharma-licensing-deal-glp-1/\">Source Link</a>\n\n</div>\n","source":"investor_business_daily_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck Joins The Weight-Loss Race, Inking $2.01 Billion Deal To Take On Eli Lilly, Pfizer, Roche</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck Joins The Weight-Loss Race, Inking $2.01 Billion Deal To Take On Eli Lilly, Pfizer, Roche\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-18 22:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/news/technology/merck-weight-loss-drugs-hansoh-pharma-licensing-deal-glp-1/><strong>Blockhead</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck (MRK) threw its hat into the obesity race on Wednesday, inking a deal worth up to $2.01 billion with China's Hansoh Pharma for its experimental weight-loss drug.\n\n\n\n↑\nX\n\n\n\n\nThe Weight-Loss Drug ...</p>\n\n<a href=\"https://www.investors.com/news/technology/merck-weight-loss-drugs-hansoh-pharma-licensing-deal-glp-1/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.investors.com/news/technology/merck-weight-loss-drugs-hansoh-pharma-licensing-deal-glp-1/","article_id":"2492118997","we_media_id":null,"thumbnails":["https://www.investors.com/wp-content/uploads/2018/04/stock-Merck-03-shutter-150x150.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492118997","pubTimestamp":1734530846,"columns":[],"sourceInfo":{"source_id":"investor_business_daily_highlight","name":"Investor’s Business Daily"},"weMediaInfo":null,"summary":"Merck threw its hat into the obesity race on Wednesday, inking a deal worth up to $2.01 billion with Hansoh Pharma for its weight-loss drug.","collect":0,"end_time":0,"defaultTopTitle":"investors.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","LU0882574139.USD":"富达环球消费行业基金A ACC","PFE":"辉瑞","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","SG9999014898.SGD":"United Global Quality Growth Fund Dis SGD","LU0265550359.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A2\" (USD) ACC","GPCR":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","RHHBY":"罗氏控股","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","MRK":"默沙东","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0094547139.USD":"abrdn SICAV I - GLOBAL SUSTAINABLE EQUITY FUND \"A\" (USD) ACC","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0385154629.USD":"贝莱德营养科学基金A2","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","LLY":"礼来","PFE.AU":"PANTERA MINERALS LTD","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","AZN":"阿斯利康","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","VKTX":"Viking Therapeutics, Inc.","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","03165":"华夏欧优股对冲","SGXZ51526630.SGD":"大华环球创新基金A Acc SGD","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","LU0985481810.HKD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (HKD) INC M","BK4516":"特朗普概念","LU0058720904.USD":"联博国际健康护理基金A","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU2361044865.SGD":"WELLINGTON US QUALITY GROWTH \"A\" (SGDHDG) ACC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","SG9999015341.SGD":"United Income Focus Trust Acc SGD-H","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC"},"translate_title":"默克加入减肥竞赛，签署20.1亿美元协议挑战礼来、辉瑞、罗氏","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AZN":1,"VKTX":1,"RHHBY":1,"PFE.AU":1,"PFE":1,"MRK":1,"LLY":1,"GPCR":1,"03165":0.6},"content_text":"Merck (MRK) threw its hat into the obesity race on Wednesday, inking a deal worth up to $2.01 billion with China's Hansoh Pharma for its experimental weight-loss drug.\n\n\n\n↑\nX\n\n\n\n\nThe Weight-Loss Drug Market Is Hot. Which Medical Stock Will Win The Battle For Supremacy?\n\n\nSee All Videos\n\n\n\n\nNOW PLAYING\nThe Weight-Loss Drug Market Is Hot. Which Medical Stock Will Win The Battle For Supremacy?\n\n\n\n\nThe licensing deal focuses on HS-10535, a pill that mimics the GLP-1 receptor to improve feelings of satiety and markers of blood sugar. Under the terms of the deal, Merck will pay Hansoh $112 million up front to develop, manufacture and commercialize HS-10535. Hansoh is also eligible to receive up to $1.9 billion in milestone payments as well as royalties on sales.\n\"Through this agreement, we aim to build on our experience targeting incretin biology to evaluate HS-10535 and its potential to provide additional cardiometabolic benefits beyond weight reduction,\" Dean Yi, president of Merck Research Laboratories, said in a statement.\nMerck already sells Januvia, a type 2 diabetes treatment that also targets an incretin. Incretins, which include GLP-1, are gut hormones that stimulate the pancreas and are involved in releasing insulin. Januvia works by blocking an enzyme called DPP-4. DPP-4 plays a role in glucose metabolism.\nThe weight-loss pills space could be huge. But the field is getting crowded. It includes big names like Eli Lilly (LLY), Pfizer (PFE), Roche (RHHBY) and AstraZeneca (AZN). Smaller companies Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are also in this space.\nMore to follow.\nFollow Allison Gatlin on X, the platform formerly known as Twitter, at @IBD_AGatlin.\nYOU MAY ALSO LIKE:\nTeva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug\nPfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy\nIBD Stock Of The Day: See How To Find, Track And Buy The Best Stocks\nSee Stocks On The List Of Leaders Near A Buy Point\nFind Today's Best Growth Stocks To Watch With IBD 50","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492118997"}